Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Cross-border transfer increases patients’ risk of resistant bacteriaArchived
Patient transfer between hospitals and in particular between countries, is a risk factor for the spread of bacteria that are resistant to last-line antibiotics. More specifically, for highly resistant bacteria, like carbapenamase-producing Enterobacteriaceae (CPE), the risk is heightened when patients are transferred from, or have received previous medical care in areas with high rates of bacterial resistance. These are conclusions from a risk assessment produced by ECDC that evaluated the risk to the citizens of Europe, of the spread of CPE through patient transfer between healthcare facilities, with special emphasis on cross-border transfer.
ECDC experts on country visit to GreeceArchived
Following an invitation from Greek authorities, ECDC Director Marc Sprenger and experts from the ECDC Programmes for Sexually Transmitted Infections including HIV and blood-borne infections and Antimicrobial Resistance and Healthcare-associated Infections will visit Greece on 29 and 30 November 2012.
Survey on antimicrobial resistance in intensive care units currently open
Antibiotic resistance is a threat to public health. It compromises the treatment of infected patients, in particular that of the most severely ill patients. Increasingly, intensive care physicians in Europe are confronted with infections caused by bacteria for which limited or no adequate treatment options are available.
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain
Thirteen patients with OXA-48-producing Klebsiella pneumoniae ST392 have been reported by Sweden and Norway between January and April 2018 - all returning travellers with prior hospital admission in Gran Canaria. Whole genome sequencing showed tight clustering between the bacterial isolates from the cases.
Survey of healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance
On 28 January, Public Health England (PHE) launched a new multilingual survey, funded by the European Centre for Disease Prevention and Control (ECDC), which aims to gain an understanding of European healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance.